LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 15 of 15: Calculated dose-response metrics. - Dataset (ID:20252)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | GR_AOC |
|---|---|---|
| SK-BR-3 | GW843682X | 0.9221 |
| SK-BR-3 | HG-5-113-01 | 0.6622 |
| SK-BR-3 | HG-5-88-01 | 0.3895 |
| SK-BR-3 | HG-6-64-01 | 0.3681 |
| SK-BR-3 | Imatinib | -0.0675 |
| SK-BR-3 | JNK-9L | 0.6699 |
| SK-BR-3 | JW-7-24-1 | 0.5594 |
| SK-BR-3 | KIN001-043 | 0.2662 |
| SK-BR-3 | Lapatinib | 0.9977 |
| SK-BR-3 | LDN-193189 | 0.3261 |
| SK-BR-3 | Linifanib | -0.0102 |
| SK-BR-3 | Linsitinib | 0.2753 |
| SK-BR-3 | Mitoxantrone | 1.2311 |
| SK-BR-3 | MK2206 | 0.5779 |
| SK-BR-3 | Neratinib | 1.1603 |
| SK-BR-3 | Nilotinib | -0.0290 |
| SK-BR-3 | Nintedanib | 0.1927 |
| SK-BR-3 | NU7441 | 0.2374 |
| SK-BR-3 | NVP-AEW541 | 0.0874 |
| SK-BR-3 | Luminespib | 0.9963 |
| SK-BR-3 | NVP-TAE684 | 0.3840 |
| SK-BR-3 | OSI-027 | 0.8180 |
| SK-BR-3 | Palbociclib | 0.3825 |
| SK-BR-3 | PD0325901 | 0.2859 |
| SK-BR-3 | PD173074 | -0.0160 |